Exclusive-Intel looks to put millions more into SambaNova startup chaired by CEO Tan

Intel plans to invest an additional $15 million in SambaNova, which would raise its stake to 9% (after a $35 million February investment that lifted Intel’s holding to 8.2% from 6.8% last year). Reuters identified three other Tan-affiliated startups with Intel investments: $2.3M for a 14% stake in OPAQUE (implying a ~$41M valuation), $3.4M for ~5% of EPIC Microsystems, and $8M into 3D Glass Solutions via Intel Capital. The disclosures and past pursuit of deals benefiting CEO Lip-Bu Tan have raised governance and conflict-of-interest concerns, though SambaNova says 2025 was record-breaking and it is refocusing on inference workloads and a new chip.

Analysis

Intel’s accelerated dealmaking with CEO‑affiliated startups increases an underappreciated governance premium that investors will price into the stock over the next 3–12 months. Repeated small-to-mid sized venture checks can aggregate into meaningful capital deployment that competes with core capex and buybacks; if even a subset of these bets requires write‑downs or restructuring, expect 5–15% incremental compression of the multiple as visible ROIC deteriorates.

Competitive dynamics favor incumbents with scale in AI silicon: independent GPU/accelerator leaders retain pricing power and ecosystem lock‑in, so any marginal benefit to Intel from external tie‑ups is likely to accelerate product readiness but not immediately close the performance or software moat. Second‑order winners include advanced packaging and custom board suppliers that benefit from any consolidation of startup IP into incumbents, while smaller pure‑software AI stacks face renewed risk of being bundled into integrated hardware+software offerings.

Key catalysts and risks to monitor are: 1) disclosure or regulatory scrutiny that forces additional transparency (weeks–months), 2) quarterly reporting that shows either incremental cash burn or impairment (next 1–4 quarters), and 3) activist investor moves or board scrutiny which could force exits or reversals (3–12 months). A reversal is plausible if these investments begin showing tangible product wins that materially accelerate revenue acceleration or margin improvement, which would re‑rate the stock over 12–24 months.

Key Decisions for Investors

• Short INTC vs long NVDA (pair trade), 3–12 month horizon: size 1:0.5 (dollar neutral). Rationale: governance/conflict risk compresses INTC multiple while NVDA captures AI demand. Target 15–25% relative outperformance; hedge NVDA delta with 1–2% of portfolio risk budget.
• Buy a 3–6 month INTC put spread (buy 20% OTM / sell 10% OTM) as a low‑cost asymmetric hedge: max loss = premium; payoff begins if headline governance or impairment risks drive a >10% pullback. Use ahead of next quarterly filing or any proxy/filing deadline.
• If conviction in NVDA’s ecosystem persists, buy 3–6 month NVDA calls (light allocation) to express upside from market share capture; pair with the INTC put spread to create a low‑capital, directional pair with capped downside. Expect higher theta—manage by rolling into earnings windows.
• Monitor for activist signals or regulatory letters—if they appear, increase short INTC exposure and add single‑name CDS protection or additional puts with 6–12 month expiries; if instead product wins surface (revenue cadence or customer announcements), flip to a modest long INTC stance with tight stop.